These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

681 related items for PubMed ID: 22166632

  • 41. Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic.
    Li YX, Shi Z, Aibaidula A, Chen H, Tang Q, Li KK, Chung NY, Chan DT, Poon WS, Mao Y, Wu J, Zhou L, Chan AK, Ng HK.
    Oncotarget; 2016 Oct 04; 7(40):64615-64630. PubMed ID: 27556304
    [Abstract] [Full Text] [Related]

  • 42. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
    Felsberg J, Rapp M, Loeser S, Fimmers R, Stummer W, Goeppert M, Steiger HJ, Friedensdorf B, Reifenberger G, Sabel MC.
    Clin Cancer Res; 2009 Nov 01; 15(21):6683-93. PubMed ID: 19861461
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Molecular genetic markers as predictors of response to chemotherapy in gliomas.
    Idbaih A, Omuro A, Ducray F, Hoang-Xuan K.
    Curr Opin Oncol; 2007 Nov 01; 19(6):606-11. PubMed ID: 17906460
    [Abstract] [Full Text] [Related]

  • 47. Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens.
    Gelpi E, Ambros IM, Birner P, Luegmayr A, Drlicek M, Fischer I, Kleinert R, Maier H, Huemer M, Gatterbauer B, Anton J, Rössler K, Budka H, Ambros PF, Hainfellner JA.
    Mod Pathol; 2003 Jul 01; 16(7):708-15. PubMed ID: 12861068
    [Abstract] [Full Text] [Related]

  • 48. Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma.
    Shamsara J, Sharif S, Afsharnezhad S, Lotfi M, Raziee HR, Ghaffarzadegan K, Moradi A, Rahighi S, Behravan J.
    Cancer Invest; 2009 Oct 01; 27(8):825-9. PubMed ID: 19544111
    [Abstract] [Full Text] [Related]

  • 49. Novel genomic alterations and mechanisms associated with tumor progression in oligodendroglioma and mixed oligoastrocytoma.
    Blesa D, Mollejo M, Ruano Y, de Lope AR, Fiaño C, Ribalta T, García JF, Campos-Martín Y, Hernández-Moneo JL, Cigudosa JC, Meléndez B.
    J Neuropathol Exp Neurol; 2009 Mar 01; 68(3):274-85. PubMed ID: 19225409
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas.
    Lin AL, Liu J, Evans J, Leuthardt EC, Rich KM, Dacey RG, Dowling JL, Kim AH, Zipfel GJ, Grubb RL, Huang J, Robinson CG, Simpson JR, Linette GP, Chicoine MR, Tran DD.
    Neuro Oncol; 2014 Jan 01; 16(1):123-30. PubMed ID: 24285548
    [Abstract] [Full Text] [Related]

  • 55. Gliomas with 1p/19q codeletion: a.k.a. oligodendroglioma.
    Cairncross G, Jenkins R.
    Cancer J; 2008 Jan 01; 14(6):352-7. PubMed ID: 19060598
    [Abstract] [Full Text] [Related]

  • 56. Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.
    van den Bent MJ, Looijenga LH, Langenberg K, Dinjens W, Graveland W, Uytdewilligen L, Sillevis Smitt PA, Jenkins RB, Kros JM.
    Cancer; 2003 Mar 01; 97(5):1276-84. PubMed ID: 12599236
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation.
    Wick W, Meisner C, Hentschel B, Platten M, Schilling A, Wiestler B, Sabel MC, Koeppen S, Ketter R, Weiler M, Tabatabai G, von Deimling A, Gramatzki D, Westphal M, Schackert G, Loeffler M, Simon M, Reifenberger G, Weller M.
    Neurology; 2013 Oct 22; 81(17):1515-22. PubMed ID: 24068788
    [Abstract] [Full Text] [Related]

  • 59. IDH1 mutation of gliomas with long-term survival analysis.
    Myung JK, Cho HJ, Park CK, Kim SK, Phi JH, Park SH.
    Oncol Rep; 2012 Nov 22; 28(5):1639-44. PubMed ID: 22922798
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.